Opendata, web and dolomites

UNLOCK-EDD SIGNED

UNLOCKing next generation computer-guided Enzyme Discovery and Design.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 UNLOCK-EDD project word cloud

Explore the words cloud of the UNLOCK-EDD project. It provides you a very rough idea of what is the project "UNLOCK-EDD" about.

synthesis    thousands    computer    lower    fast    global    respected    biocatalyst    chemical    tests    2022    17m    11    silico    tima    biomedical    phd    resolution    industry    sales    breakeven    replace    slow    additional    multiple    carg    emanuele    cso    predictions    reached    chemistry    delivering    gil    house    reference    industries    organically    advantage    90    capture    outcomes    lucas    profile    thanks    industrial    costly    2018    landed    model    reputation    experimental    services    start    pharmaceutical    67b    aacute    licensing    monza    allowed    american    enzyme    business    biocatalysts    maria    made    cto    months    seeing    victor    fine    enhanced    excellent    custom    market    ceo    platform    team    representing    specialized    harness    computing    founding    variants    grown    cut    members    projected    simulations    first    plan    15    physics    convert    computational    pioneering    discovery    time    obstacle    virtual    engineering    compounds    hold    uncertain    engineered    north    company    optimize    9b    enzymes    accelerate    reactions    molecular    rely    power    performance    2024    royalty    protein    50    zymvol    revenue    entering    fold    commodity    traction   

Project "UNLOCK-EDD" data sheet

The following table provides information about the project.

Coordinator
ZYMVOL BIOMODELING SL 

Organization address
address: PASEO DE RONDA 78 1 1
city: LLEIDA
postcode: 25006
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙859˙281 €
 EC max contribution 1˙301˙496 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ZYMVOL BIOMODELING SL ES (LLEIDA) coordinator 1˙301˙496.00

Map

 Project objective

ZYMVOL is start-up specialized in computer-driven biocatalyst discovery and development for the pharmaceutical and fine chemical industry. We harness the power of high-performance computing to identify and optimize custom-made biocatalysts that deliver additional value. Biocatalysts are enzymes that accelerate industrial chemical reactions and have multiple applications for the synthesis of chemical compounds. Engineered enzymes can provide improved performance, representing a unique advantage. The protein engineering market is a fast-growing business estimated to reach 2.67B€ by 2024 (CARG 15%). The main obstacle today to performance enhanced biocatalysts is that current enzyme engineering processes rely on slow and costly experimental tests with uncertain outcomes. Our in-silico engineering platform can rapidly find thousands of enzyme variants delivering reliable predictions, that allow to replace up to 90% of experimental tests, making the enzyme development cost (10-fold lower) and time (cut by 50%) effective. ZYMVOL aims to be the reference in the computer-driven enzyme engineering market and convert molecular modelling in a commodity. In addition to our virtual enzyme sales (we plan to capture €11.17M by 2022 after entering into the North American market), we will promote a royalty-based revenue model from licensing enzymes developed in-house (global enzyme market is projected to reach €9B by 2024). ZYMVOL’s founding team is composed by Maria Fátima Lucas, CEO, Emanuele Monza, CSO and Victor Gil, CTO. All members of the team hold a PhD in chemistry, physics and biomedical engineering. The Company is seeing excellent traction which has allowed it to grown organically in its first 20 months. Thanks to a services-based business model it has already reached breakeven in 2018. The Company has quickly landed some high-profile business and developed a respected reputation by pioneering the access to high resolution computational simulations for all industries.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UNLOCK-EDD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UNLOCK-EDD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Manuback (2019)

MANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More  

Nocturne (2019)

The eye as a window to the brain, extending lifelong brain health

Read More